Outcome of Board Meeting held on 02nd June, 2026 - expansion of Manufacturing capacity at Ankleshwar Plant, Gujarat
ELANTAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 3.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Elantas Beck India, at its meeting on 2 June 2026, approved an investment of approximately Rs. 56 crores to expand manufacturing capacity at its Ankleshwar, Gujarat plant. The existing capacity stands at 35,000 MT per year, running at about 90% utilisation, and the expansion will add 11,000 MT per year (roughly a 31% capacity increase). The project is targeted to be completed within 12 months and will be funded entirely through internal accruals, with no debt being raised. The company stated the rationale as supporting future business growth, easing operational bottlenecks, and improving supply reliability for key product segments.
This is a growth-oriented capex announcement funded entirely from internal cash, so there is no dilution or debt burden for shareholders. The expansion addresses high existing capacity utilisation and should support future revenue growth, though benefits will only flow in after the 12-month execution window.